We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current CFRX market cap is 2.48M. The company's latest EPS is USD -6.0863 and P/E is -0.04.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -20.03M | -21.9M | -6.7M | -8.86M | -7.98M |
| Net Income | -18.09M | -17.07M | -9.84M | -1.37M | -7.57M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -31.12M | -27.87M | -34.24M | -47.27M | -64.61M |
| Net Income | -37.68M | -12.79M | -28.16M | -20.28M | -65.15M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 40.8M | 23.03M | 20.68M | 20.55M | 19.25M |
| Total Liabilities | 27.91M | 26.14M | 32.53M | 23.69M | 20.36M |
| Total Equity | 12.89M | -3.1M | -11.85M | -3.14M | -1.11M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 32.87M | 35.01M | 51.12M | 66.76M | 20.68M |
| Total Liabilities | 27.33M | 19.46M | 38.5M | 17.39M | 32.53M |
| Total Equity | 5.54M | 15.55M | 12.62M | 49.38M | -11.85M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -26.35M | -36.01M | -45.97M | -8.8M | -16.95M |
| Investing | 19.25M | 24.02M | 32.08M | 2.75M | 4.73M |
| Financing | N/A | N/A | 6.14M | 9.01M | 17.73M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -26.26M | -27.43M | -33.19M | -41.13M | -45.97M |
| Investing | 17.15M | 21.97M | -27.4M | -11.61M | 32.08M |
| Financing | 10.43M | 21.32M | 51.89M | 53.91M | 6.14M |
| Market Cap | 2.48M |
| Price to Earnings Ratio | -0.04 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.28 |
| Price to Book Ratio | -0.21 |
| Dividend Yield | - |
| Shares Outstanding | 10.7M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 132.74k |
| 52 Week Change | -98.05% |
| 52 Week High | 13.016 |
| 52 Week Low | 0.20 |
| Spread (Intraday) | 0 (0.04%) |
| Company Name | ContraFect Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.contrafect.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
